IL-4 haplotype -590T, -34T and Intron-3 VNTR R2 is associated with reduced malaria risk among ancestral Indian tribal populations by Jha, Aditya Nath et al.
IL-4 Haplotype -590T, -34T and Intron-3 VNTR R2 Is
Associated with Reduced Malaria Risk among Ancestral
Indian Tribal Populations
Aditya Nath Jha1, Vipin Kumar Singh1, Namrata Kumari1, Ashish Singh1, Justin Antony2, Hoang van
Tong2, Sakshi Singh1, Sudhanshu S. Pati3, Pradeep K. Patra4, Rajender Singh5, Nguyen L. Toan6,
Le H. Song7, Amal Assaf8, Iara J. T. Messias–Reason9, Thirumalaisamy P. Velavan2, Lalji Singh1,10,
Kumarasamy Thangaraj1*
1Centre for Cellular and Molecular Biology, CSIR, Hyderabad, India, 2 Institute of Tropical Medicine, University of Tu¨bingen, Tu¨bingen, Germany, 3 Ispat General Hospital,
Rourkela, Orissa, India, 4 Pt. Jawaharlal Nehru Memorial Medical College, Raipur, India, 5Central Drug Research Institute, CSIR, Lucknow, India, 6Department of
Pathophysiology, Vietnam Military Medical University, Hanoi, Vietnam, 7 Tran Hung Dao Hospital, Hanoi, Vietnam, 8Department of Laboratory Medicine, University of
Damascus, Damascus, Syria, 9 Laborato´rio de Imunopatologia Molecular-Hospital de Clı´nicas, Federal University of Parana´, Curitiba, Brazil, 10 Banaras Hindu University,
Varanasi, India
Abstract
Background: Interleukin 4 (IL-4) is an anti-inflammatory cytokine, which regulates balance between TH1 and TH2 immune
response, immunoglobulin class switching and humoral immunity. Polymorphisms in this gene have been reported to affect
the risk of infectious and autoimmune diseases.
Methods: We have analyzed three regulatory IL-4 polymorphisms; -590C.T, -34C.T and 70 bp intron-3 VNTR, in 4216
individuals; including: (1) 430 ethnically matched case-control groups (173 severe malaria, 101 mild malaria and 156
asymptomatic); (2) 3452 individuals from 76 linguistically and geographically distinct endogamous populations of India, and
(3) 334 individuals with different ancestry from outside India (84 Brazilian, 104 Syrian, and 146 Vietnamese).
Results: The -590T, -34T and intron-3 VNTR R2 alleles were found to be associated with reduced malaria risk (P,0.001 for -
590C.T and -34C.T, and P = 0.003 for VNTR). These three alleles were in strong LD (r2.0.75) and the TTR2 (-590T, -34T and
intron-3 VNTR R2) haplotype appeared to be a susceptibility factor for malaria (P = 0.009, OR = 0.552, 95% CI = 0.356 –0.854).
Allele and genotype frequencies differ significantly between caste, nomadic, tribe and ancestral tribal populations (ATP).
The distribution of protective haplotype TTR2 was found to be significant (x23 = 182.95, p-value ,0.001), which is highest in
ATP (40.5%); intermediate in tribes (33%); and lowest in caste (17.8%) and nomadic (21.6%).
Conclusions: Our study suggests that the IL-4 polymorphisms regulate host susceptibility to malaria and disease
progression. TTR2 haplotype, which gives protection against malaria, is high among ATPs. Since they inhabited in isolation
and mainly practice hunter-gatherer lifestyles and exposed to various parasites, IL-4 TTR2 haplotype might be under positive
selection.
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Introduction
Plasmodium falciparum malaria is one of the major causes of
morbidity and mortality in tropical and sub-tropical areas [1].
Despite the significant advances in disease control, Plasmodium
falciparum malaria accounts for 1–3 million deaths annually [2].
The variation in the severity of Plasmodium falciparum infections
include different phenotypes such as hyper or asymptomatic
parasitaemia, mild malaria, severe malaria and cerebral malaria
[3,4] and the host genetic architecture contribute to these malarial
phenotypes [5]. Increasing epidemiological and experimental
evidences suggest that the host genetic variations play an essential
role to thwart actively or passively the parasite invasion. [4]. The
fundamental attribute of the innate immune system is to recognize
pathogen and react swiftly to contain the early infection while
signaling to specific adaptive immune response. Studies have
investigated role of innate immune genes such as Toll-like
receptors (TLR2, 4, 9), chemokines and cytokines role in
Plasmodium falciparum malaria [6]. In addition, plethora of studies
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have documented that genetic heterogeneity in many immune
genes is associated with malaria susceptibility [3].
Malarial infection is characterized by pro-inflammatory re-
sponses during early stages of infection followed by anti-
inflammatory responses during disease progression [7]. The
human Interleukin 4 (IL-4) located in the chromosome 5 (5q31-
33), is an anti-inflammatory cytokine produced by CD4+ Th2
cells, basophils and mast cells. IL-4 regulates variety of cell types
[8] and play an essential role in differentiation of Th2 effector
cells, suppression of Th1 signaling, promoting humoral immunity
and Ig class switching and a dominant role in immunopathology
[9,10,11]. Studies have revealed that INF-c levels were signifi-
cantly elevated during early stages of malaria, whereas the IL-4
levels were elevated during intermediate and late stages indicating
a switch towards Th2 response [12]. A significant inverse
correlation between IL-4 to INF-c ratio and peripheral parasit-
aemia in malaria patients has been documented [13].
Human IL-4 gene promoter contains six conserved binding sites
of NFAT (nuclear factor of activated T-cells), a transcription
factor; along with activator protein 1 (AP1) regulates IL-4
transcription [14]. Studies have shown that the -590C/T
transition creates a seventh NFAT binding site and synergistically
up regulates IL-4 transcription rate up to 3 fold [15]. Studies have
documented that elevated antibody IgG and IgE levels against
malaria antigens, parasitaemia and malaria susceptibility has been
associated with IL-4 -590T allele in several African populations
[8,16,17,18,19]. The -590T allele is believed to be under positive
selection in various populations and indicates local adaptation to
diverse pathogenic challenges [20]. Further, -34T promoter
polymorphism association with elevated total serum IgE levels
has been demonstrated [8]. Also the presence of H3K27Ac mark
was observed near active regulatory element of intron-3 VNTR
region in different cell lines (www.ucsc.edu). Studies have
established that IL-4 as a key regulator in malaria and three
regulatory IL-4 polymorphisms (-590C/T, -34C/T and in intron-
3 VNTR) have been shown to regulate serum IL-4 levels, IgG,
IgE, disease progression and survival
[16,17,18,19,21,22,23,24,25]. Also the three regulatory polymor-
phisms in the IL-4 loci were associated with end stage renal
disease, multiple sclerosis, autoimmune Grave’s disease, chronic
polyarthritis, rheumatoid arthritis, asthma, rhinitis and atopic
dermatitis [21,26,27,28,29].
Although several studies have documented on functional
significance of IL-4 polymorphisms in different ethnicities, to the
best of our knowledge no studies have investigated the contribu-
tion of IL-4 variants in Indian population. Indian populations
remain isolated from rest of the world for thousands of years and
are unique in their origin and have accumulated unique set of
mutations and the variants influencing disease susceptibility
among Indian populations remain different compared to other
ethnicities [30–31]. In this study, we aim to investigate the
contribution of three functional IL-4 polymorphisms rs2243250 (-
590 C.T, promoter), rs2070874 (-34 C.T, 59UTR) and
rs79071878 (intron-3, 70 bp VNTR) with P. falciparum malaria
infection in well-defined malaria cases and in ethnically matched
controls. Since the entire Indian subcontinent represents a malaria
endemic region, we extended our investigation of the three
functional IL-4 polymorphisms to different linguistically and
geographically isolated Indian populations and compared the
observed differences to that of different ethnicities representing
world populations.
Materials and Methods
Study Subjects
A total of 4216 individuals were investigated for IL-4 gene
polymorphisms (-590C/T, -34C/T and in intron-3 VNTR). Of
which 173 individuals were clinically characterized with Plasmo-
dium falciparum severe malaria and 101 with mild malaria and 156
with asymptomatic individuals from P. falciparum endemic states,
Orissa and Chhattisgarh (Table 1). We also utilized 3452
individuals from 76 distinct populations representing caste
(n = 1568), nomadic (n = 114), tribes (n = 517) and ancestral tribal
populations [(ATP) (n = 1253)] of India. Also three world
populations representing tropical regions such as Brazil (n = 84),
Syria (n = 104) and Vietnam (n= 146) were included in this study
(Table 2).
Sampling
All individuals representing the malaria cohort were clinically
classified. Classification of malaria was carried out on WHO
guidelines; severe malaria (n = 173) is defined as severe anemia
(hemoglobin ,50 g/l) and/or hyper-parasitemia (.250,000
parasites/ml, corresponding to .10% infected erythrocytes), a
Blantyre coma score #2 and other facultative signs of severe
malaria such as cerebral malaria, convulsions, hypoglycemia, and
respiratory distress. All individuals were hospitalized for treatment.
Mild malaria (n = 101) is defined as parasitemia 1000–50,000/ml
on admission, no schizontaemia, circulating leukocytes containing
malarial pigment ,50/ml, not homozygous for hemoglobin S,
hemoglobin .80 g/l, platelets .50/nl, leukocytes ,12/nl, lactate
,3 mmol/l, and blood glucose .50 mg/dl. Asymptomatic
individuals (n = 156) were characterized as individuals harboring
parasites without clinical signs during sample collection. Intra-
venous blood sample (,5 ml) was collected from each individual
admitted at Ispat General Hospital, Rourkela, India; and Pt.
Jawaharlal Nehru Memorial Medical College, Raipur, India.
Table 1. Characteristics of studied subjects segregated
according to clinical classification.
Sample Size Mean Age (year)± SD
Male:
Female
Asymptomatic 156 29.87619.57 92:64
Mild Malaria 101 30.24615.71 67:34
Severe Malaria 173 26.11612.38 103:70
doi:10.1371/journal.pone.0048136.t001
Table 2. Characteristics of studied subjects of various world
populations.
Ethnicity Population No. of individuals
India Caste 1568
Nomadic 114
Tribe 517
Ancestral tribes 1253
Brazil Brazil 84
Syria Syria 104
Vietnam Vietnam 146
doi:10.1371/journal.pone.0048136.t002
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Ethical Committee Approval
An informed written consent was obtained from every
individual. The study was approved by the Institutional Ethical
Committee (IEC) of Centre for Cellular and Molecular Biology,
Hyderabad, India; Ispat General Hospital, Rourkela, Orissa,
India; and Pt. Jawaharlal Nehru Memorial Medical College,
Raipur, Chhattisgarh, India.
Genotyping of SNP and VNTR Variants
Genomic DNA was extracted from whole blood using the
protocol as previously described [32]. To re-sequence 800 bp of
IL-4 promoter region, we utilized the reference sequence from the
ENSEMBL (ID: ENSG00000113520; www.ensembl.org). The
sequence specific primer pairs were designed using the Primer-
BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast), Mac-
Vector (MacVector, Inc. USA) and the Amplify 3X (http://engels.
genetics.wisc.edu/amplify) software platforms.
DNA was amplified using a primer pair spanning the promoter
regions to detect polymorphisms at -590C/T and -34C/T
variants. The primer pairs employed were IL-4_promo_F: 59-
TATGGACCTGCTGGGACCCAAACTA-39, and IL-4_pro-
mo_R: 59-CACCTTCTGCTCTGTGAGGCTGTTC-39 (Euro-
fiins mwg operon). In brief: 5 ng of genomic DNA was amplified
in a 10 ml reaction volume using Qiagen long-range PCR kit
following manufacturers instructions (Qiagen, Germany) on a
GeneAmp 9700 Thermal cycler (ABI, USA). Thermal cycling
parameters for amplification were: initial denaturation at 94uC for
3 min, followed by 35 cycles of 30 sec at 93uC denaturation,
25 sec at 66uC annealing, 1 min 30 sec at 68uC extension,
followed by a final extension of 5 min at 68uC. PCR products were
cleaned up using Exo-SAP-IT (USB, Affymetrix, USA) and 1 ml of
the purified product were directly used as templates for
sequencing, using the BigDye terminator v. 3.1 cycle sequencing
kit Applied Biosystems, USA) on an ABI 3730XL DNA sequencer,
according to the manufacturer’s instructions. DNA polymor-
Figure 1. Distribution of IL-4 intron-3 VNTR polymorphism. A and B: genotype and allelic distribution between malaria case control groups,
respectively; C and D: genotype and allelic distribution among caste, nomadic, tribe and ancestral tribe, respectively.
doi:10.1371/journal.pone.0048136.g001
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phisms were identified when assembled with the reference
sequence using AutoAssembler software (Applied Biosystems).
The variable nucleotide repeat regions (VNTR) in the intron-3
were amplified using primer pairs IL-4_del_70_F: 59-GCCTTTA-
GATTCCACCACGAGTATG-39 and IL-4_del_70_R: 59-
GGTCATCTTTTCCTCCCCTGTATCTTA-39. PCR products
were size fractionated on 2% agarose gel to detect the repeat
polymorphisms. PCR amplicons of 389 bp (two repeats each of
70 bp) were designated as R2 whereas amplicons of 459 bp (three
repeats, each of 70 bp) as R3. A subset of samples were
reconfirmed and validated for their R2 and R3 polymorphisms
by direct sequencing.
Statistical Analysis
The allele and genotype frequencies were analyzed by simple
gene counting and expectation-maximum (EM) algorithm and the
significance of deviations from Hardy-Weinberg equilibrium was
tested using the random-permutation procedure as implemented
in the Arlequin v.3.5.1.2 software (http://cmpg.unibe.ch/
software/arlequin3/) [33]. Pairwise Fst values and co-ancestry
coefficient were calculated using Arlequin using un-phased data
Figure 2. Linkage Disequilibrium (LD) of studied IL-4 loci (-590 C/T, -34 C/T and intron-3 VNTR) in malaria case control and Indian
population groups. The three studied SNPs are in strong LD (r2.0.75, malaria case control groups; r2.0.87, population groups).
doi:10.1371/journal.pone.0048136.g002
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Linkage disequilibrium (LD) analysis was performed using Haplo-
view v4.2 software [34]. The allele and genotype distribution were
calculated by chi square test in different sample sets using the
SPSS (ver. 20). In all analysis, a two tailed p-value less than 0.05
were considered significant. Chi square contingency-table test
results were interpreted by standardized residual method of post
hoc analysis [35]. Probable effect of sex stratification and sample
size were verified by bootstrap (10000 random sampling events)
with bias-corrected and accelerated (BCa) method, using SPSS
(ver. 20).
Results
Role of IL-4 Variants in Malaria
The distributions of IL-4 genotype and allele frequencies are
summarized in Table 3 and Figure 1. Mainly two copies and three
copies of 70 bp repeat (intron-3 VNTR) has been observed in
humans and are designated as R2 and R3 respectively, whereas
only a single copy of 70 bp repeat has been observed in other
primates (Figure S1, www.ensembl.org). The genotype frequencies
of intron-3 VNTR polymorphism differed significantly among
ethnically matched asymptomatic controls, individuals with mild
and severe malaria (x24 = 42.2; p,0.001). Promoter polymor-
phisms -590 C.T and -34 C.T also differed significantly among
the studied malarial sub groups (x24 = 19.5; p,0.001 and
x24 = 25.3; p,0.001). Similarly, allele distributions also differed
significantly among these groups (intron-3 VNTR: x22 = 30.3;
p,0.001, -590 C.T x22 = 13.6; p,0.001 and -34 C.T
x22 = 11.3; p = 0.003). All three studied loci were in HW
equilibrium and were in strong LD (r2.0.75) (Figure 2) with
two major haplotypes, CCR3 and TTR2 identified (Table S2).
Therefore, analysis has been performed only with VNTR
polymorphism or the resulting haplotypes. Significant difference
has been observed in the distribution of these haplotypes between
cases and asymptomatic control (OR=0.552, 95%
CI= 0.35620.854, p = 0.009) (Table S2) with TTR2 as protective
haplotype.
Post-hoc analysis of chi-square contingency-table test showed
over representation of genotype R3R2 (57.1%; z score = 5.5) and
under representation of R3R3 (30.8%; z score =26.1) genotypes
in asymptomatic control; while over representation of R3R3
[(mild, 65.3%; z score = 3.5), (severe, 59.0%; z score = 3.0)] and
under representation of R2R3 [(mild, 30.7%; z score =22.1),
(severe, 29.5%; z score =23.6)] and R2R2 [(mild, 4%; z
score =22.3) (severe, 59.0%; z score = 0.9)] in mild and severe
malaria group and mainly contributes to the Chi-square
[(Figure 1), (Table S1)]. Comparison of mild and severe malaria
genotype distribution shows non-significant difference between
these two groups x22 = 4.6; p= 0.097; while significant difference
was observed between asymptomatic vs. mild (x22 = 30.2;
p,0.001) and asymptomatic vs. severe malaria (x22 = 28.9;
p,0.001) (Table 4). Since it has been reported that TT
homozygous and CT heterozygous at position -590 and -34,
R2R2 and R2R3 genotype leads to higher serum IL-4 level [22],
we pooled R2R2 and R2R3 for further analysis. Again,
comparison of R2R2+R2R3 vs. R3R3 between various groups
Table 3. Distribution of IL4 genotypes and alleles in patients with malaria and in asymptomatic controls.
SNP ID and Polymorphism Genotype (%)
Genotype
Comparison Allele (%) Allele Comparison
x24 P-value x
2
2 P-value
rs79071878, R2/R3 R2R2 R2R3 R3R3 R2 R3
Asymptomatic 19 (12.2) 89 (57.1) 48 (30.8) 127 (40.7) 185 (59.3)
Mild Malaria 4 (4.0) 31 (30.7) 66 (65.3) 39 (19.3) 163 (80.7)
Severe Malaria 20 (11.6) 51 (29.5) 102 (59.0) 42.2 ,0.001 91 (26.3) 255 (73.7) 30.3 ,0.001
rs2070874, -34C/T TT TC CC T C
Asymptomatic 15 (9.6) 83 (53.2) 58 (37.2) 113 (36.2) 199 (63.8)
Mild Malaria 2 (2.0) 39 (38.6) 60 (59.4) 43 (21.2) 159 (78.7)
Severe Malaria 19 (11.0) 54 (31.2) 100 (57.8) 25.3 ,0.001 92 (26.6) 254 (73.4) 13.6 ,0.001
rs2243250, -590 C/T TT TC CC T C
Asymptomatic 15 (9.6) 80 (51.3) 61 (39.1) 110 (35.3) 202 (64.7)
Mild Malaria 4 (4.0) 37 (36.6) 60 (59.4) 45 (22.3) 157 (77.7)
Severe Malaria 19 (11) 54 (31.2) 100 (57.8) 19.5 ,0.001 92 (26.6) 254 (73.4) 11.3 0.003
doi:10.1371/journal.pone.0048136.t003
Table 4. Genotype comparison among various groups of
malaria case control and population study in multiple stages.
Group 1 Vs. Group 2 R2R2, R2R3, R3R3 (R2R2+R2R3) Vs. R3R3
x22 p-value x
2
1 p-value
Malaria case-control groups
Asymptomatic Mild Malaria 30.2 ,0.001 28.3 ,0.001
Asymptomatic Severe
Malaria
28.9 ,0.001 25.1 ,0.001
Mild Malaria Severe
Malaria
4.6 0.097 1.1 0.293
Asymptomatic Pooled Cases38.0 ,0.001 35.8 ,0.001*
Population groups
Caste Nomadic 3.48 0.175 2.9 0.08
Caste Tribe 118.9 ,0.001 101.4 ,0.001
Caste ATP 482.5 ,0.001 437.9 ,0.001
Tribe ATP 44.32 ,0.001 40.0 ,0.001
*OR = 3.566, 95% CI = 2.348–5.416;
doi:10.1371/journal.pone.0048136.t004
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show statistically significant difference, except between mild and
severe malaria x21 = 1.1 p= 0.293 (Table 4). Therefore, we pooled
mild and severe group together and compared with asymptomatic
control, which came out to be highly significant [x21 = 35.8;
OR=3.566, 95% CI= 2.348–5.416 p,0.001] (Table 4).
As the proportion of male sample were higher in asymptomatic
as well as in case groups, we further analyzed the distribution of
R2/R3 in these groups for the possible effect of sex stratification.
The frequency of protective allele R2 was found significantly lower
in both the male and female groups of mild and severe malaria
compared to asymptomatic control and rule out the possibility of
sex stratification (Table S3).
Association of Haplotype TTR2 with Ancestral and Tribal
Indian Population
Among 3613 individuals from a total of 76 endogamous Indian
ethnic populations investigated, we found striking pattern of
genotype prevalence based on their social status and inhabitation.
Most of the studied populations were in HW equilibrium (Table 5)
and those, which were not in HW, were excluded for further
analysis. Based on their social status, inhabitation, co-ancestry
coefficient and pairwise Fst (Figure S2), we initially grouped these
populations into three groups; namely, caste, nomadic and tribal
populations. Caste is further grouped in to traditionally upper,
middle and lower caste populations to see if there is any difference
between these groups. Our study did not find any significant
difference in genotype distribution among these groups (Figure
S3). Further, tribal group has been divided into two groups the
tribe (started agriculture recently) and the ancestral tribal
population [(ATP), which includes all hunter-gatherer tribal
populations]. The genotype distribution of these three loci (-
590C/T, -34C/T and the intron-3 VNTR) differed significantly
among the four classified sub groups (x26 = 501.1; p,0.001,
x26 = 326.9; p,0.001 and x
2
6 = 323.2; p,0.001) respectively
(Table 6). In addition, allelic distributions differed also significantly
(Table 6). We found these markers in strong LD having r2.0.87
(Figure 2) with significant difference in haplotype distribution
among these four subgroups (x23 = 182.95, p-value,0.001) (Table
S2). The protective haplotype TTR2 has been found to be highest
in ATP (40.5%); intermediate in tribes (33%); and lowest in caste
(17.8%) and nomadic (21.6%) (Figure 3).
The genotype proportions between caste and nomadic did not
differ significantly x22 = 3.48; p= 0.175, however, it differ signif-
icantly between caste vs. tribe; caste vs. ATP; and tribe vs. ATP
with x22 = 118.9; p,0.001, x
2
2 = 482.5; p,0.001 and x
2
2 = 44.32;
p,0.001, respectively (Table 4). We have also pooled R2R2 and
R2R3 genotype together in agreement with higher IL-4 serum
level [27] and compared with R3R3 genotype and found
significant difference in genotype distribution between caste vs.
tribe; caste vs. ATP; and tribe vs. ATP pairs with x21 = 101.4;
p,0.001, x21 = 437.9; p,0.001 and x
2
1 = 40.0; p,0.001, respec-
tively (Table 4). Post-hoc analysis of chi-square contingency-table
test result show over representation of genotype R3R3 (68.8%; z
score = 19.6) and under representation of genotype R2R3 (27.2%;
z score =212.2) and R2R2 (4.1%; z score =212.3) in caste while
ancestral population ATP showed over representation of R2R3
(51.0%; z score = 11.1) and R2R2 (21.0%; z score = 12.9) and
under representation of R3R3 (28.0%; z score =218.9) genotype.
Tribal group showed intermediate of caste and ATP [(R2R2,
13%; z score = 1.3), (R2R3, 43.1%; z score = 2.6), (R2R2, 43.9%;
z score =23.4)] (Figure 1) (Table S1).
Since there are four major linguistic families in India, we
classified the samples in to four groups, namely; Indo-European
(IE), Dravidian (DV), Austro-Asiatic (AA) and Tibeto-Burman
(TB). Each linguistic family has been further classified in to caste,
tribe and ATP. Interestingly, the difference in genotype distribu-
tion among caste, tribe and ATP follow the same pattern as of
TTR2 haplotype distribution in ATP (highest), tribe and caste
(lowest) populations (Figure 4).
Geographical Distribution of IL-4 Variants
Comparison of all three studied variants to other world
populations (Syria, Brazilian and Vietnamese) revealed diverse
geographical patterns. We retrieved earlier reported data and
compared with Indian population. We found Vietnamese has very
high R2R2 (65.7%) genotype frequency, similar to other Southeast
Asian countries. However, R2R2 genotype frequency in Syrian
and Brazilian were only 4.8% and 6%, respectively (Figure S4).
Figure 3. Haplotype distribution among various Indian social groups. The prevalence of protective haplotype TTR2 is significantly higher in
ancestral tribal populations.
doi:10.1371/journal.pone.0048136.g003
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Table 5. Social status, geographical origin, ethnicity, linguistic affiliation and HW equilibrium of Indian populations included in
present study.
S. No. Population
Social
Designation
Language
Family State
Sample
Size R2R2(%) R2R3(%) R3R3(%) Obs.Het. Exp.Het. P-value
1 Kapu Caste Dravidian Andhra Pradesh 57 2(3.51) 17(29.82) 38(66.67) 0.298 0.303 1
2 Reddy Caste Dravidian Andhra Pradesh 56 1(1.79) 14(25) 41(73.21) 0.25 0.247 1
3 Vysya Caste Dravidian Andhra Pradesh 48 0(0) 8(16.67) 40(83.33) 0.167 0.154 1
4 Yadav Caste Dravidian Pudduchery 48 1(2.08) 7(14.58) 40(83.33) 0.146 0.171 0.3365
5 Achari Caste Dravidian Tamil Nadu 71 3(4.23) 17(23.94) 51(71.83) 0.239 0.273 0.3714
6 Gugavellar Caste Dravidian Tamil Nadu 68 1(1.47) 11(16.18) 56(82.35) 0.161 0.174 0.4696
7 Lingayat Caste Dravidian Tamil Nadu 47 1(2.13) 12(25.53) 34(72.34) 0.255 0.256 1
8 Muppanar Caste Dravidian Tamil Nadu 15 1(6.67) 4(26.67) 10(66.67) 0.267 0.331 0.4612
9 Muthaliar Caste Dravidian Tamil Nadu 43 3(6.98) 11(25.58) 29(67.44) 0.256 0.319 0.0855
10 Pillai Caste Dravidian Tamil Nadu 79 4(5.1) 17(21.52) 58(73.42) 0.215 0.266 0.2676
11 Sonakar Caste Indo-European Chhattisgarh 41 0(0) 11(26.83) 30(73.17) 0.268 0.235 1
12 Lohana Caste Indo-European Gujarat 46 1(2.17) 11(23.91) 34(73.91) 0.239 0.245 1
13 Tadavi Caste Indo-European Gujarat 22 0(0) 8(36.36) 14(63.64) 0.363 0.301 0.3141
14 Bania Caste Indo-European Hariyana 34 1(2.94) 10(29.41) 23(67.65) 0.294 0.295 1
15 Pandit Caste Indo-European Hariyana 15 1(6.67) 3(20) 11(73.33) 0.2 0.287 0.3250
16 SC Caste Indo-European Hariyana 40 2(5) 11(27.5) 27(67.5) 0.275 0.308 0.5995
17 Kamboj Caste Indo-European Haryana 100 0(0) 30(30) 70(70) 0.3 0.256 0.1169
18 KashGujjar Caste Indo-European Kashmir 44 3(6.81) 12(27.27) 29(65.91) 0.273 0.315 0.6439
19 KashMushlim Caste Indo-European Kashmir 57 2(3.51) 21(36.84) 34(59.65) 0.368 0.345 1
20 KashPandit Caste Indo-European Kashmir 47 2(4.26) 14(29.79) 31(65.96) 0.298 0.312 0.6604
21 Baghel Caste Indo-European Madhya Pradesh 35 0(0) 13(37.14) 22(62.86) 0.371 0.307 0.5678
22 Silawat Caste Indo-European Madhya Pradesh 90 6(6.67) 31(34.44) 53(58.89) 0.344 0.383 0.8623
23 Jatav Caste Indo-European Rajasthan 36 3(8.33) 10(27.78) 23(63.89) 0.2778 0.351 0.3241
24 Kurmi Caste Indo-European Rajasthan 56 3(5.36) 14(25) 39(69.64) 0.25 0.296 0.3502
25 Meena Caste Indo-European Rajasthan 41 1(2.44) 9(21.95) 31(75.61) 0.219 0.235 0.5384
26 Brahmins Caste Indo-European Uttar Pradesh 59 2(3.39) 14(23.73) 43(72.88) 0.237 0.261 0.6056
27 Kshatriya Caste Indo-European Uttar Pradesh 40 1(2.5) 8(20) 31(77.5) 0.2 0.221 0.4732
28 Khatri Caste Indo-European Punjab 30 2(6.67) 8(26.67) 20(66.67) 0.267 0.325 0.3060
29 Bisht Caste Indo-European Uttarakhand 45 1(2.22) 9(20) 35(77.78) 0.2 0.217 0.5007
30 Rawat Caste Indo-European Uttarakhand 87 10(11.49) 34(39.08) 43(49.43) 0.391 0.430 0.4571
31 Darj_caste Caste Indo-European West Bengal 32 3(9.3) 14(43.75) 15(46.88) 0.437 0.448 0.6923
32 Thapa Caste Tibeto-Burman Nepal 39 3(7.69) 13(33.33) 23(58.97) 0.333 0.373 0.6607
33 Banjara Nomadic Indo-European Rajasthan 42 1(2.38) 14(33.33) 27(64.29) 0.333 0.312 1
34 NariKuruwar Nomadic Indo-European Tamil Nadu 72 4(5.56) 26(36.11) 42(58.33) 0.361 0.363 1
35 BodoGadaba ATP Austro-Asiatic Andhra Pradesh 39 4(10.26) 26(66.67) 9(23.08) 0.667 0.498 0.0501
36 Chenchu ATP Austro-Asiatic Andhra Pradesh 45 7(15.56) 17(37.78) 21(46.67) 0.378 0.457 0.3213
37 Asur ATP Austro-Asiatic Jharkhand 45 6(13.33) 23(51.11) 16(35.56) 0.511 0.481 0.7568
38 Bhumij ATP Austro-Asiatic Jharkhand 91 14(15.38) 42(46.15) 35(38.46) 0.461 0.476 0.8257
39 Birhor ATP Austro-Asiatic Jharkhand 59 10(16.95) 27(45.76) 22(37.29) 0.457 0.483 0.7860
40 Kharia ATP Austro-Asiatic Jharkhand 41 4(9.76) 22(53.66) 15(36.59) 0.536 0.470 0.5009
41 Parharia ATP Austro-Asiatic Jharkhand 19 7(36.84) 11(57.89) 1(5.26) 0.579 0.462 0.3436
42 Saharia ATP Austro-Asiatic Madhya Pradesh 30 3(10) 17(56.67) 10(33.33) 0.567 0.481 0.4446
43 Bondo ATP Austro-Asiatic Orissa 40 8(20) 24(60) 8(20) 0.6 0.506 0.3411
44 Didayi ATP Austro-Asiatic Orissa 30 8(26.67) 11(36.67) 11(36.67) 0.366 0.503 0.1575
45 Andamani ATP Andamanese Andaman 18 1(5.56) 9(50) 8(44.44) 0.5 0.436 1
46 KondaReddy ATP Dravidian Andhra Pradesh 15 4(26.67) 7(46.67) 4(26.67) 0.466 0.517 1
47 KondaSavara ATP Dravidian Andhra Pradesh 93 37(39.78) 52(55.91) 4(4.3) 0.559 0.439 0.0890
48 Porja ATP Dravidian Andhra Pradesh 69 23(33.33) 32(46.38) 14(20.29) 0.463 0.495 0.6314
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Discussion
We have screened the regulatory polymorphisms of IL-4
promoter region (rs2243250, -590CT and rs2070874, -34 CT)
and intron-3 repeat region (rs79071878, 70 bp VNTR) to
investigate their possible role in survival against disease and
pathogen or infection employing three different approaches: (1)
case-control malaria cohort from Orissa and Chhattisgarh, the
malaria endemic regions of India; (2) a comprehensive assessment
in seventy-six ethnically, linguistically and geographically diverse
populations inhabited across India; and (3) evaluation of samples
from Brazil, Syria and Vietnam and comparison of results with
Indian populations.
We observed significant difference in genotype and allele
frequency distribution along with haplotype carriage between
three groups of malaria case-control study. However, mild and
severe groups do not differ among themselves; they differ
significantly when compared to asymptomatic control. We also
found these regulatory markers are in strong LD (r2.0.75) and
carriage of the resultant haplotype TTR2 with asymptomatic and
CCR3 with malaria cases (OR=0.552, 95%CI= 0.356–0.854,
p = 0.009) (Table S2). Malaria outcome is the result of complex
interaction of a large number of factors and the pathogenesis
might be regulated by various mechanisms. However, our findings
show that the high IL-4 producing haplotype TTR2 protects or
increases survival against Plasmodium falciparum malaria. It has been
reported that the carriers of TT with cerebral malaria had
elevated total IgE compared to non-carriers and suggested that the
IL-4 play a regulatory role in the pathogenesis of malaria in
Ghanaian children [8]. Further, association between IL-4 -590T
allele and lower prevalence of Plasmodium falciparum infection in
asymptomatic Fulani population of Mali has been documented
[36]. Several findings have shown association of -590T, -34T and
intron-3 VNTR polymorphism R2 with high level of serum IL-4
and consequent high level of total IgG, IgE, anti-plasmodium IgG
and IgE, and severity of infection in several populations of malaria
endemic region across the globe [16,17,18,19,21,22,23,24,25,37].
It has been established that the high level of pro-inflammatory
cytokines (TNF-a, IFN-c) produced during malaria infection leads
to severe pathogenesis [38,39,40,41,42,43]. These cytokine up-
regulates expressions of endothelial adhesion molecules (ICAM-1)
in brain and kidney, which facilitates increased sequestration of
Table 5. Cont.
S. No. Population
Social
Designation
Language
Family State
Sample
Size R2R2(%) R2R3(%) R3R3(%) Obs.Het. Exp.Het. P-value
49 Kattunayakan ATP Dravidian Kerala 47 4(8.51) 22(46.81) 21(44.68) 0.468 0.439 0.7444
50 Paniyas ATP Dravidian Kerala 33 7(21.21) 20(60.61) 6(18.18) 0.606 0.507 0.3072
51 Kuruman ATP Dravidian Kerela 25 7(28) 12(48) 6(24) 0.48 0.509 1
52 Kurumba ATP Dravidian Tamil Nadu 43 3(6.98) 21(48.84) 19(44.19) 0.488 0.436 0.4959
53 Kathodi ATP Indo-European Gujarat 10 2(20) 4(40) 4(40) 0.4 0.505 0.5729
54 Kotwali ATP Indo-European Gujarat 100 10(10) 52(52) 38(38) 0.52 0.463 0.2806
55 Katkari ATP Indo-European Maharashtra 16 6(37.5) 6(37.5) 4(25) 0.375 0.508 0.3476
56 Baiga ATP Indo-European Madhya Pradesh 60 9(15) 40(66.67) 11(18.33) 0.666 0.503 0.0188
57 Buxa ATP Indo-European Uttar Pradesh 46 13(28.26) 26(56.52) 7(15.22) 0.565 0.497 0.3806
58 Onge ATP Jarwa-Onge Andaman_nikobar 11 3(27.27) 7(63.64) 1(9.09) 0.636 0.506 0.5532
59 Mizo ATP Tibeto-Burman Mizoram 15 8(53.33) 6(40) 1(6.67) 0.4 0.404 1
60 AoNaga ATP Tibeto-Burman Nagaland 34 17(50) 12(35.29) 5(14.71) 0.352 0.425 0.2575
61 Juang ATP Tibeto-Burman Orissa 69 15(21.74) 35(50.72) 19(27.54) 0.507 0.502 1
62 Korku Tribe Austro-Asiatic Madhya Pradesh 42 6(14.29) 19(45.24) 17(40.48) 0.452 0.471 1
63 Koia Tribe Dravidian Andhra Pradesh 86 6(6.97) 40(46.51) 40(46.51) 0.465 0.422 0.6098
64 Kotiya Tribe Dravidian Andhra Pradesh 23 7(30.43) 11(47.83) 5(21.74) 0.478 0.507 1
65 Oddari Tribe Dravidian Andhra Pradesh 19 2(10.53) 6(31.58) 11(57.89) 0.316 0.398 0.5492
66 Halaki Tribe Dravidian Karnataka 36 1(2.78) 14(38.89) 21(58.33) 0.389 0.350 0.6563
67 Malayan Tribe Dravidian Kerala 41 5(12.2) 21(51.22) 15(36.59) 0.512 0.476 0.7435
68 Muthan Tribe Dravidian Kerala 61 7(11.47) 24(39.34) 30(49.18) 0.393 0.429 0.2782
69 Kolcha Tribe Indo-European Gujarat 59 2(3.39) 30(50.85) 27(45.76) 0.508 0.413 0.1119
70 MahadeoKoli Tribe Indo-European Maharashtra 51 8(15.69) 23(45.1) 20(39.22) 0.451 0.476 0.7695
71 Tharu Tribe Indo-European Uttarakhand 48 11(22.92) 20(41.67) 17(35.42) 0.417 0.497 0.3758
72 Nyshi Tribe Tibeto-Burman Arunachal Pradesh 10 8(80) 2(20) 0(0) 0.2 0.189 1
73 Darj_tribe Tribe Tibeto-Burman West Bengal 11 3(27.27) 5(45.45) 3(27.27) 0.455 0.523 1
74 Malaikuruwar ATP Dravidian Tamil Nadu 62 4(6.45) 5(8.06) 53(85.48) 0.081 0.189 0.0006
75 Toda ATP Dravidian Tamil Nadu 48 3(6.25) 3(6.25) 42(87.50) 0.062 0.171 0.0014
76 Ulladan Tribe Dravidian Kerala 30 1(3.3) 8(26.66) 21(70.00) 0.266 0.278 0.1613
R2: Two Repeat of IL-4 intro-3 VNTR, R3: Three repeat, ATP: Ancestral Tribal Population, Obs.Het : Observed heterozygocity, Exp.Het : Expected heterozygocity, P-value in
bold shows departure from HW equilibrium at 0.05 level.
doi:10.1371/journal.pone.0048136.t005
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parasitized RBC within the microvasculature of these organs
[38,39]. This increased sequestration of parasitized RBC leads to
cerebral malaria and renal failure. Further, inhibitory effect of
TNF-a on erythropoiesis and subsequent severe malarial patho-
genesis has been demonstrated in human and mouse model of
experimental cerebral malaria (ECM) [41,42,43]. In ECM mouse
model, treatment with anti-inflammatory cytokine IFN-a and
IFN-ß inhibited cerebral malaria and reduced the parasite burden
[39,40]. IFN-ß treatment down regulate pro-inflammatory cyto-
kine TNF-a, IFN-c, ICAM-1, CXCL9 and CXCR3 [40]. These
studies indicate, a check on pro-inflammatory cytokine by anti-
inflammatory cytokine can lead to enhanced survival against
Plasmodium falciparum malaria. This supports our finding that shows
high IL-4 producing haplotype, TTR2, provide decreased
susceptibility to Plasmodium infection.
In contrast to the general accepted view that IL-4 secreting
CD4+ T cells are anti-inflammatory mediators and suppress pro-
inflammatory response, CD4+ T cells has been found to be crucial
to the development of pro-inflammatory CD8+ T cell response
against Plasmodium sporozoite infected hepatocytes [44,45,46]. It
has been observed that early development of protective circum-
sporozoite protein (CSP) specific CD8+ T cell originates in
cutaneous lymphoid tissue of infected site and then migrate to
other sites including liver [47,48]. Development of this immunity
requires IL-4 mediated cross talk of CD4/CD8 cells [44]. The
CSP specific CD8+ T cells, which get primed in presence of IL-4
signals, differentiate into effector memory CD8+ T cells, whereas
in absence of IL-4 the response fails to develop further after few
days and reduced by more than 90% compared to that in presence
of CD4+ T cells. These recent reports further support our findings
[44].
In this study, among Indian populations, we found over-
representation of R2R2 and R2R3 genotype in ATP while under-
representation in caste and vice-versa. No significant difference in
genotype or allele distribution has been found between caste and
nomadic populations. Our Y-chromosomal markers based popu-
lation study explains that this deviation from general perception is
due to recent admixture and gene flow between the caste and
nomadic populations (our unpublished data). However, significant
difference has been found between all other groups. Every single
Indian population maintain its unique genetic architecture; mainly
due to endogamy marriage practice over the last thousands of
year. This has been well supported by our earlier studies using
mtDNA, Y chromosome and autosomal genetic markers [30,31].
We found that these three markers are in strong LD (r2.0.87) with
two main haplotypes TTR2 and CCR3. Distribution of protective
haplotype TTR2 has been found significantly higher in ATP than
tribe and caste while at intermediary in tribe. The ATPs are
inhabited in isolated forest and they mainly practice hunter-
gatherer lifestyle, hence, they are under constant exposure to
helminthes and various other parasites. Therefore, positive
selection [20] might be operating on IL-4 locus of the ATPs
compared to caste populations, who practice modern lifestyle and
expose to modern medicine.
This is the first study of its kind, where we studied the IL-4
variations in such a depth in diverse Indian populations. We also
observed that a few populations (Bodo, Gadaba, Baiga, Toda,
Malai Kuruwar) are significantly departs from HW equilibrium,
which might be the result of positive selection or founder effect as
their population size are very small and follow very strict
endogamy practice.
Apart from its role in controlling malaria and other pathogenic
disease, the IL-4 polymorphisms (-590T, -34T and intron-3
VNTR R2) have been found to be associated with end stage
renal disease, multiple sclerosis, autoimmune Grave’s disease,
polyarthritis, rheumatoid arthritis, asthma, rhinitis and atopic
dermatitis [21,26,27,28,29]. This Th2 response also mediates
inflammatory response to helminth infection [49]. This indicates
ATP and tribal populations not only have more survival potential
against autoimmune and allergic disease but also against
extracellular helminthic infection then the caste populations.
Table 6. Genotype and allele distribution of IL-4 intron-3 VNTR polymorphism, -34CT and -590CT in various groups of Indian
population.
Genotype (%) Genotypic Comparison Allele (%)
x26 p-value x
2
3 p-value
rs79071878, R2/R3 R2R2 R2R3 R3R3 R2 R3
Caste 64 (4.1) 426 (27.2) 1078 (68.8) 554 (17.7) 2582 (82.3)
Nomadic 5 (4.4) 40 (35.1) 69 (60.5) 50 (21.9) 178 (78.1)
Tribe 67 (13.0) 223 (43.1) 227 (43.9) 357 (34.5) 677 (65.5)
ATP 240 (21.0) 583 (51.0) 320 (28.0) 501.1 ,0.001 1063 (46.5) 1223 (53.5) 537.6 ,0.001
rs2070874, -34 C/T TT TC CC T C
Caste 67 (4.4) 443 (28.2) 1058 (67.4) 577 (18.4) 2559 (81.6)
Nomadic 6 (5.3) 39 (34.2) 69 (60.5) 51 (22.4) 177 (77.6)
Tribe 63 (12.2) 239 (46.2) 215 (41.6) 365 (35.3) 669 (64.7)
ATP 205 (17.9) 519 (45.4) 419 (36.7) 323.2 ,0.001 929 (40.6) 1357 (59.4) 347.9 ,0.001
rs2243250, -590 C/T TT TC CC T C
Caste 71 (4.5) 439 (28.0) 1058 (67.5) 581 (18.5) 2555 (81.5)
Nomadic 6 (5.3) 39 (34.2) 69 (60.5) 51 (22.4) 177 (77.6)
Tribe 63 (12.2) 236 (45.6) 218 (42.2) 362 (35.0) 672 (65.0)
ATP 212 (18.5) 514 (45.0) 417 (36.5) 326.9 ,0.001 938 (41.0) 1348 (59.0) 351.4 ,0.001
ATP: ancestral tribal population.
doi:10.1371/journal.pone.0048136.t006
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In conclusion, IL-4 -590T, -34T and intron-3 VNTR R2 allele
is associated with enhanced survival against malaria and other
extracellular pathogens in Indian populations. However, their role
needs to be assessed further for other infectious, inflammatory and
autoimmune diseases. This observation may assist in finding
individuals at high risk and hence, disease management. These
linked marker along with other markers being in LD can cause
balance shift of cytokine profile and hence TH1 and TH2 response
in an individual up to an extent, where it can be deleterious also.
Thus, a delicate balance of various cytokine is more important
than the specific one. Hence, for detailed understanding, other
regulators need to be studied among Indian populations. Our
study also emphasize the importance of host genetics in resistance/
susceptibility to infectious disease.
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